We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Name | Symbol | Market | Type |
|---|---|---|---|
| Novartis AG | NYSE:NVS | NYSE | Depository Receipt |
| Price Change | % Change | Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| -1.62 | -1.64% | 97.44 | 98.22 | 97.44 | 97.76 | 1,562,845 | 01:00:00 |
From Apr 2021 to Apr 2024
By Mauro Orru
BASF SE said Monday that it has agreed with Sandoz GmbH, a subsidiary of Swiss pharmaceutical major Novartis AG, to make investments at the company's Kundl/Schaftenau Campus in Austria.
The German chemicals company didn't disclose financial details for the agreement signed on April 26, which is aimed at bolstering BASF's production footprint for enzymes and biotechnology products.
The start of production is planned for 2024, BASF said.
Write to Mauro Orru at mauro.orru@wsj.com; @MauroOrru94
(END) Dow Jones Newswires
May 03, 2021 09:44 ET (13:44 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Novartis Chart |
1 Month Novartis Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
